Rare Fibrodysplasia Ossificans Progressiva Case Documented in New UAE Medical Publication

Understanding Fibrodysplasia Ossificans Progressiva: The 'Stone Man' Syndrome

Fibrodysplasia Ossificans Progressiva (FOP), often called the 'stone man syndrome,' is an ultra-rare genetic disorder that causes soft tissues like muscles, tendons, and ligaments to progressively turn into bone outside the normal skeleton. This heterotopic ossification leads to a 'second skeleton' that severely restricts movement, often resulting in permanent disability. Affecting approximately 1 in 1-2 million people worldwide, FOP is caused primarily by a mutation in the ACVR1 gene, which regulates bone morphogenetic protein (BMP) signaling.

Patients typically present with congenital malformations of the great toes, known as bilateral hallux valgus, and experience 'flare-ups'—painful inflammatory episodes triggered by trauma, infections, or spontaneously. These flare-ups precede the formation of rigid bone bridges, locking joints and impairing functions like breathing, eating, and mobility over time. Early diagnosis is crucial, yet often delayed due to misdiagnosis as cancer, infection, or aggressive juvenile fibromatosis.

A Groundbreaking Case Report from the UAE: First Genetically Confirmed FOP

In a landmark publication dated March 11, 2026, researchers from the University of Sharjah and Al Qassimi Hospital documented the first genetically confirmed case of FOP in the United Arab Emirates. Published in Cureus (DOI: 10.7759/cureus.105022), the case involves a 15-year-old Sudanese girl who has been living with the condition since infancy.

The patient was diagnosed at age two after presenting with painful shoulder restriction. Recurrent flare-ups, triggered by minor trauma and infections, led to progressive heterotopic ossification affecting her jaw (causing ankylosis), hips (resulting in gait impairment), and now her right forearm. On August 15, 2025, she sought care at Al Qassimi Hospital for acute forearm and hand swelling mistaken initially for cellulitis. Imaging confirmed FOP flare-up, but corticosteroids were not administered as it was beyond the 24-hour window for optimal intervention.

Born with bilateral hallux valgus and macrodactyly, her family history includes a paternal aunt with similar toe malformations, hinting at possible incomplete penetrance. Genetic testing confirmed the classic ACVR1 mutation, distinguishing this from the lone prior UAE report in 2019, which lacked confirmation.

Patient Journey: From Infancy to Wheelchair Dependence

The girl's journey exemplifies FOP's relentless progression. Initial symptoms emerged in infancy with shoulder stiffness, followed by episodic swellings misinterpreted as infections. Over 13 years, ossification spread axially and proximally, typical of FOP's 'double dorsal-to-ventral, cranial-to-caudal' pattern. Jaw involvement prevented full mouth opening, hip ossification necessitated a wheelchair, and the recent forearm flare-up fixed her elbow at 90 degrees.

• Infancy (age 0-2): Shoulder restriction and toe malformations noted.
• Childhood (age 2-10): Recurrent flare-ups post-trauma/infection, jaw and neck ossification begins.
• Adolescence (age 10-15): Hip involvement impairs walking; forearm flare leads to hospital admission.

Current management emphasizes supportive care: gentle physiotherapy to maintain residual mobility, pain control with NSAIDs, and family education on avoiding triggers like biopsies, intramuscular injections, or falls. No curative options exist, but the case stresses early flare-up recognition.

Diagnostic Challenges and the Role of Genetic Confirmation

FOP diagnosis hinges on clinical triad: progressive heterotopic ossification, hallux valgus, and ACVR1 mutation (97% R206H variant). Imaging shows 'fluffy' densities evolving to mature bone. In the UAE case, initial misdiagnosis as cellulitis highlights pitfalls in resource-rich yet low-prevalence settings. Genetic testing via next-generation sequencing provided definitive proof, underscoring UAE's advanced genomics infrastructure.

University of Sharjah's involvement—authors Tabarak M. Al Karam and Batool M. Alkaram from its College of Medicine—demonstrates how UAE higher education bridges clinical care and research. This affiliation enhances credibility and trains future physicians in rare disease management.

Photo by Risto Kokkonen on Unsplash

UAE's Advancing Landscape in Rare Disease Research and Care

The UAE invests heavily in precision medicine, with the Centre for Arab Genomic Studies (CAGS) cataloging over 665 genetic disorders in Emiratis. Institutions like Khalifa University and UAE University (UAEU) pioneer genetic research, including joint projects on rare diseases.

Palovarotene (Sohonos), a retinoic acid receptor gamma (RARγ) agonist, is provisionally approved in the UAE, reducing new bone formation during flares. Trials like Ipsen's FALKON and Regeneron's garetosmab offer hope, with UAE patients potentially accessing them via compassionate use.

Dubai Medical University fosters awareness through collaborations like with LeadPath, preparing students for rare disease challenges.

Management Strategies: Preventative Care and Flare-Up Protocols

1. Avoid Triggers: No elective surgery, vaccinations subcutaneous, dental cleanings prophylactic antibiotics.
2. Flare-Ups: High-dose corticosteroids within 24 hours, NSAIDs/COX-2 inhibitors.
3. Supportive: Range-of-motion exercises, assistive devices, multidisciplinary team (orthopedics, genetics, physio).
4. Emerging: Palovarotene chronic prophylaxis; anti-ALK2 inhibitors in trials.

The UAE case followed these, but delayed presentation limited steroids. Family counseling emphasized prompt care-seeking.

UAE Universities Driving Rare Disease Innovation

University of Sharjah's medical graduates contribute to cases like this, gaining hands-on rare disease experience. Khalifa University's genetic engineering center and UAEU's Khalifa Center for Genetic Engineering & Biotechnology focus on arid-region genomics, extendable to rare disorders.

These institutions offer higher ed jobs in genetics and pediatrics, fostering research careers. Aspiring professionals can explore UAE university jobs amid growing precision medicine focus.

Implications for Medical Education and Training in the UAE

This case elevates UAE medical curricula, integrating rare diseases via simulations and genomics. Dubai Medical University's interprofessional efforts prepare students for complex cases, enhancing higher ed career advice for specialists.

Programs at University of Sharjah emphasize multidisciplinary approaches, vital for FOP's holistic care.

Photo by Europeana on Unsplash

Global Context and Future Outlook for FOP in the UAE

Globally, over 1,500 cases documented; UAE's contributes to Middle East data. Ongoing trials (FALKON, LUMINA-1) promise ALK2 inhibitors. UAE's genomic databases position it for personalized therapies.

Stakeholders: patients via IFOPA, researchers at UAE unis, policymakers advancing UAE Centennial 2071 health goals.

Actionable Insights for Healthcare Providers and Researchers

• Recognize hallux valgus + swellings as FOP red flags.
• Prioritize genetic testing in atypical ossification.
• Educate on flare protocols; collaborate with genetics.
• Join UAE rare disease networks for trials.

For careers, UAE unis offer university jobs in rare disease research. Explore rate my professor for mentors.